RaySearch Laboratories AB (publ) announces the launch of RayStation 12A, the latest version of the company’s advanced treatment planning system

July 25, 2022 —  RaySearch Laboratories AB announces the launch of RayStation* 12A, the latest version of the company’s advanced treatment planning system. Version 12A includes innovative new features in addition to several general enhancements. 

Deep Learning Segmentation for All Users

With the release of RayStation 12A, deep learning segmentation is available for everyone that is using RayStation for patient modeling. New and updated segmentation models will be released on a regular basis. The segmentation models can be linked to segmentation templates and protocols and used to tailor fast and automated segmentation for different body sites and diagnoses.  

Brachy Planning for Elekta Afterloaders

RayStation 12A supports brachy planning for Elekta Flexitron afterloaders. The dedicated brachy planning module allows rapid creation of optimal and accurate high-dose rate brachytherapy treatment plans. Automatic tools can be used to efficiently reconstruct the applicator and its channels. With RayStation’s powerful optimization tools, optimal dwell time distributions can be obtained within seconds. 

Other highlights of RayStation 12A include robust evaluation on multiple images, new and much faster electron Monte Carlo dose engine, and improvements for CyberKnife planning. 

Johan Löf, founder and CEO, RaySearch, says: “Making deep learning segmentation available to all users will substantially reduce time for contouring of organs and is a good example of our ambition to automate the treatment planning process.” 

* Subject to regulatory clearance in some markets. 

For more information: www.raysearchlabs.com


Related Content

News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
Subscribe Now